New hope for kids with chronic upset stomach: drug trial shows promise
NCT ID NCT04526119
First seen Mar 28, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests a medicine called Z-338 in children aged 9 to 17 who have functional dyspepsia, a condition causing stomach pain and fullness after eating. The trial has two parts: first, a single dose to measure how the body processes the drug, then a 28-day treatment period where some children receive the drug and others a placebo. The goal is to see if Z-338 safely reduces symptoms like bloating and early fullness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zeria Investigative Site
Matsumoto, Nagano, Japan
Conditions
Explore the condition pages connected to this study.